News

Renovion

First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE

Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical...

Renovion

Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...

Renovion

Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer

Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief Medical Officer. Dr. Zamora will lead the Phase...

Renovion

Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...

Renovion

A breathe-easier breakthrough

Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...

Renovion

Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...

Renovion

Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership

Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...

Renovion

Renovion Announces Addition of Rich Mattingly to Board of Directors

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...

Renovion

Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis

Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...